This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

C. GORDON ZUBROD, M.D.

Arch Intern Med. 1960;106(5):663-678.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

In this review I propose to comment on those anticancer drugs which may now be considered a part of the practice of medicine and attempt to summarize what they may be expected to achieve. This resumé will be preceded by some general remarks on the management of cancer patients and followed by a consideration of some of the current research problems in cancer chemotherapy.

General Remarks

The internist is beginning to assume a major role in the study and management of the patient with cancer. The internist has always been keenly alert to the problem of early diagnosis of cancer, but in earlier years there was a considerable tendency to transfer the responsibility for management to the surgeon and radiologist. Hematologists, of course, maintained a considerable interest in the leukemias and lymphomas, but the patient with known disseminated cancer of nonhematopoietic origin was rarely admitted to the wards of . . . [Full Text PDF of this Article]

Author Affiliations
Bethesda, Md.

Footnotes
Submitted for publication June 17, 1960.

The National Cancer Institute, National Institutes of Health.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?